```html

Xanthoma Eruption

What is Xanthoma eruption?

A xanthoma eruption refers to the sudden appearance of multiple xanthomas—yellow‑orange, often dome‑shaped or flat patches that develop within the skin or tendons. These lesions are composed of lipid‑laden macrophages (called foam cells) that accumulate in the dermis and subcutaneous tissue. While a single xanthoma can be harmless, an eruption of many lesions, especially in adults, frequently signals an underlying disturbance in lipid metabolism or a systemic disease.

Because the skin is visible, xanthoma eruptions often serve as an early clue that a person’s blood lipids (cholesterol, triglycerides) are out of balance, or that another metabolic condition is present. Recognizing the pattern, location, and timing of the eruption helps clinicians narrow the cause and begin appropriate treatment.

Common Causes

Multiple conditions can trigger a xanthoma eruption. The most frequent culprits are disorders that raise circulating lipids, but non‑lipid disorders can also be responsible. Below are 10 common causes, grouped by category.

• Familial hypercholesterolemia (FH) – an autosomal‑dominant genetic defect in LDL‑receptor function that leads to markedly elevated LDL‑cholesterol.
• Familial combined hyperlipidemia (FCHL) – a polygenic disorder causing high LDL‑cholesterol, triglycerides, or both.
• Type III hyperlipoproteinemia (Dysbetalipoproteinemia) – defective apoE leads to accumulation of remnant particles.
• Familial hypertriglyceridemia – very high triglycerides (>500 mg/dL) can produce eruptive xanthomas on the trunk and extremities.
• Secondary hyperlipidemia due to uncontrolled diabetes mellitus, hypothyroidism, or nephrotic syndrome.
• Cholesterol‑rich diets & obesity – lifestyle‑related dyslipidemia can occasionally cause smaller eruptions.
• Liver disease – cholestatic disorders (e.g., primary biliary cholangitis) raise plasma cholesterol, prompting xanthomas.
• Dermatologic syndromes – such as plane xanthoma of the palmar creases associated with monoclonal gammopathies.
• Medications – especially retinoids, protease inhibitors, or corticosteroids that perturb lipid metabolism.
• Systemic illnesses – including Hodgkin lymphoma, multiple myeloma, and other hematologic cancers that produce paraproteinemia‑related xanthomas.

Associated Symptoms

Because xanthomas are a cutaneous manifestation of systemic processes, other signs and symptoms often accompany the eruption. The exact constellation depends on the underlying cause.

• Fatigue, weakness, or unexplained weight loss (possible malignancy or uncontrolled diabetes).
• Chest pain or shortness of breath – red flag for atherosclerotic cardiovascular disease, especially in FH.
• Abdominal discomfort, pancreatitis‑like pain – may indicate severe hypertriglyceridemia.
• Dry, scaly skin or hair loss – seen in hypothyroidism.
• Foamy urine, swelling (edema) – classic for nephrotic syndrome.
• Jaundice or pruritus – suggesting cholestatic liver disease.
• Neurologic symptoms (e.g., peripheral neuropathy) – occasionally linked to amyloidosis or paraproteinemia.
• Joint pain or tendon thickening – seen with tendon xanthomas (often in FH).

When to See a Doctor

Not every yellowish patch is a worrisome xanthoma, but timely evaluation is essential when:

• You notice a sudden burst of dozens of small, yellow papules, especially on the back, shoulders, buttocks, or extensor surfaces.
• The lesions are itchy, painful, or become inflamed.
• You have a personal or family history of high cholesterol, heart disease, diabetes, or thyroid problems.
• You experience any of the associated systemic symptoms listed above.
• Existing skin conditions (e.g., eczema) suddenly develop yellowish plaques.
• You are taking medications known to affect lipid levels and notice new skin changes.

Early medical assessment can uncover hidden lipid disorders and reduce long‑term cardiovascular risk.

Diagnosis

Diagnosing a xanthoma eruption involves both visual examination and laboratory/ imaging work‑up.

1. Clinical inspection

• Location and morphology (eruptive papules, tuberous xanthomas, tendon xanthomas, plane xanthomas).
• Distribution pattern – clustered on the trunk vs. along tendons.
• Presence of inflammation or secondary infection.

2. Skin biopsy (if needed)

A 3‑mm punch biopsy stained with Oil Red O or CD68 immunohistochemistry confirms lipid‑laden macrophages. Biopsy is reserved for atypical lesions or when malignancy is a concern.

3. Laboratory tests

• Lipid profile: fasting total cholesterol, LDL‑C, HDL‑C, triglycerides.
• Blood glucose & HbA1c – screen for diabetes.
• Thyroid function tests (TSH, free T4) – assess hypothyroidism.
• Renal function (creatinine, urine protein) – detect nephrotic syndrome.
• Liver enzymes and bilirubin – evaluate cholestasis.
• Serum protein electrophoresis – rule out monoclonal gammopathy when indicated.

4. Imaging

• Ultrasound or MRI of tendons can reveal deep tendon xanthomas.
• Carotid duplex or coronary calcium scoring may be ordered if cardiovascular risk is high.

5. Genetic testing

When a hereditary lipid disorder is suspected (e.g., FH), targeted genetic panels for LDLR, APOB, PCSK9, or APOE can confirm the diagnosis and guide family screening.

Treatment Options

Therapy is two‑fold: treat the skin lesions and address the underlying systemic cause.

1. Lipid‑lowering medications

• Statins (e.g., atorvastatin, rosuvastatin) – first‑line for elevated LDL‑C and for reducing cardiovascular events.
• Ezetimibe – added when statins alone are insufficient.
• PCSK9 inhibitors (evolocumab, alirocumab) – especially effective in FH or when statins are not tolerated.
• Fibrates (gemfibrozil, fenofibrate) – best for severe hypertriglyceridemia and eruptive xanthomas.
• Omega‑3 fatty acid prescriptions – EPA/DHA formulations lower triglycerides.
• In rare cases, **lipid‑apheresis** (plasma exchange) is used for refractory hyperlipidemia.

2. Management of secondary causes

• Optimizing diabetes control (insulin, metformin, GLP‑1 agonists).
• Treatment of hypothyroidism with levothyroxine.
• Renin‑angiotensin blockers or immunosuppressants for nephrotic syndrome, per nephrology guidance.
• Cholestasis treatment (ursodeoxycholic acid) in primary biliary cholangitis.

3. Dermatologic interventions

• Topical therapy – corticosteroid creams can reduce inflammation if lesions are irritated.
• Laser therapy (e.g., pulsed dye laser) may flatten superficial plane xanthomas for cosmetic reasons.
• Surgical excision – considered for isolated, bothersome tendon or tuberous xanthomas.

4. Lifestyle modifications

• Adopt a heart‑healthy diet: Mediterranean‑style eating pattern rich in fruits, vegetables, whole grains, nuts, and fatty fish.
• Limit saturated fats, trans fats, and refined carbohydrates.
• Maintain a healthy weight (BMI < 25 kg/m²) through regular physical activity— at least 150 min/week of moderate‑intensity aerobic exercise.
• Avoid tobacco and excessive alcohol, both of which worsen lipid profiles.

Prevention Tips

While you cannot always prevent a genetic lipid disorder, many modifiable factors lower the risk of a xanthoma eruption.

• Get lipid panels checked at least every 5 years (earlier if you have risk factors).
• If a family member has FH, pursue cascade screening for relatives.
• Control blood sugar and blood pressure—both affect lipid metabolism.
• Follow up with your primary care clinician after any new medication that may increase lipids.
• Stay up‑to‑date with vaccinations (e.g., hepatitis B) that protect liver health.
• For patients with chronic kidney disease, adhere to low‑protein and low‑sodium dietary recommendations to minimize proteinuria‑induced hyperlipidemia.

Emergency Warning Signs

Key Take‑aways

Xanthoma eruptions are more than a cosmetic issue; they often herald an underlying lipid disorder or systemic disease that can increase cardiovascular risk, lead to pancreatitis, or signal malignancy. Recognizing the skin signs, understanding associated symptoms, and pursuing prompt evaluation can dramatically improve long‑term health outcomes. Lifestyle changes, evidence‑based medications, and targeted treatment of the root cause together reduce lesions and protect the heart, pancreas, and kidneys.

References:

• Mayo Clinic. “Xanthomas.” https://www.mayoclinic.org. Accessed May 2026.
• National Heart, Lung, and Blood Institute (NHLBI). “Familial Hypercholesterolemia.” https://www.nhlbi.nih.gov.
• American Heart Association. “Statins: How Do They Work?” https://www.heart.org.
• Cleveland Clinic. “Eruptive Xanthoma.” https://my.clevelandclinic.org.
• World Health Organization. “Non‑communicable diseases: Cardiovascular diseases.” https://www.who.int.
• U.S. National Library of Medicine. “Lipid apheresis.” PubMed PMID: 33461849.

```